← Back to Search

Telehealth vs In-Clinic Care for Multiple Sclerosis (VIRTUAL-MS Trial)

N/A
Recruiting
Led By Marisa McGinley, DO
Research Sponsored by The Cleveland Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Ages ≥18
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 24 months
Awards & highlights

Summary

This trial is testing if telehealth can make MS care more accessible and reduce costs, while maintaining quality and patient satisfaction.

Who is the study for?
The VIRTUAL-MS trial is for adults over 18 with a recent Multiple Sclerosis (MS) diagnosis confirmed by MRI. It's designed for those who can consent to participate and don't have other health issues that need close monitoring, like severe low white blood cell count or wounds needing frequent care.
What is being tested?
This study compares MS care via telehealth to traditional in-clinic visits. It aims to see if remote care can match clinic-based care in terms of clinical outcomes, costs, and patient satisfaction while also identifying what makes telehealth work well.
What are the potential side effects?
Since this trial compares different methods of delivering healthcare rather than testing new medications, there are no direct side effects from drugs. However, participants may experience differences in the convenience or effectiveness of their MS management.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 24 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Proportion of patients with disability progression
Secondary study objectives
Change in Patient Satisfaction Questionnaire Short Form (PSQ-18)
Compare major healthcare costs

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Telehealth careExperimental Treatment1 Intervention
Telehealth visits will be performed using institutionally-approved, secure, web-based teleconferencing. The standard neurology visits will occur every 6 months with their established neurology clinician via telehealth. The comprehensive care will be offered via telehealth or within the patient's local community. The comprehensive care visits will be adapted for the individual participants' needs and symptoms, consistent with standard clinical care.
Group II: In-Clinic careActive Control1 Intervention
Standard neurology visits will be conducted in-clinic visits every 6 months with their established neurology clinician. The comprehensive MS care visits will be conducted in-clinic. The comprehensive care visits will be adapted for the individual participants' needs and symptoms, consistent with standard clinical care.

Find a Location

Who is running the clinical trial?

University of California, San FranciscoOTHER
2,551 Previous Clinical Trials
15,257,766 Total Patients Enrolled
24 Trials studying Multiple Sclerosis
2,415 Patients Enrolled for Multiple Sclerosis
University of WashingtonOTHER
1,791 Previous Clinical Trials
1,905,386 Total Patients Enrolled
24 Trials studying Multiple Sclerosis
3,532 Patients Enrolled for Multiple Sclerosis
The Cleveland ClinicLead Sponsor
1,045 Previous Clinical Trials
1,370,555 Total Patients Enrolled
19 Trials studying Multiple Sclerosis
4,028 Patients Enrolled for Multiple Sclerosis

Media Library

Multiple Sclerosis Clinical Care Delivery via standard in clinic visits Clinical Trial Eligibility Overview. Trial Name: NCT05660187 — N/A
Multiple Sclerosis Research Study Groups: Telehealth care, In-Clinic care
Multiple Sclerosis Clinical Trial 2023: Multiple Sclerosis Clinical Care Delivery via standard in clinic visits Highlights & Side Effects. Trial Name: NCT05660187 — N/A
Multiple Sclerosis Clinical Care Delivery via standard in clinic visits 2023 Treatment Timeline for Medical Study. Trial Name: NCT05660187 — N/A
~77 spots leftby Jun 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top